MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Parkinson’s Disease Diagnosed in a Patient with Anti-Musk Positive Myasthenia Gravis: Coincidence? – Case Report and Literature Review

    J. Sánchez León, T. Luise Denicol, C. Matté Dagostini, R. de Castro, A. Hilbig, A. Hoppe, C. Mello Rieder (Porto Alegre, Brazil)

    Objective: To describe a case of a male patient presenting with anti-Musk positive Myasthenia Gravis (MG) and Parkinson's Disease (PD) with an adequate response to…
  • 2025 International Congress

    A Registry for Sleep and Circadian Health Quality in Parkinson’s Disease (ReSCQu-PD)

    J. Cohen (Jacksonville, USA)

    Objective: To characterize sleep-, circadian- and disease-related factors contributing to daytime sleepiness in a cohort of people with Parkinson’s Disease (PwPD). Background: Excessive daytime sleepiness…
  • 2025 International Congress

    PINK1 activation improves outcomes in the UQCRC1 models of Parkinson’s disease

    JL. Li, CC. Chan, CH. Lin (New Taipei City, Taiwan)

    Objective: To investigate the role of chronic oxidative phosphorylation (OXPHOS) stress in mitophagy and the therapeutic potential of PINK1 activation in the UQCRC1 models of…
  • 2025 International Congress

    Profiling Neural Protein Dopaminylation in Parkinson’s disease

    W. Chen, I. Maze (NEW YORK, USA)

    Objective: The hallmark of Parkinson’s Disease is motor dysfunction from the decline in dopaminergic cells in the substantia nigra (SN), leading to the development of…
  • 2025 International Congress

    Effect of Aβ on α-synuclein propagation

    Y. Narumiya, E. Nakanishi, T. Taguchi, M. Sawamura, N. Uemura, T. Maki, T. Saito, R. Takahashi, R. Matsumoto, H. Yamakado (Nagoya, Japan)

    Objective: To investigate how amyloid-beta (Aβ) pathology affects α-synuclein (α-syn) propagation. Background: Lewy bodies, the pathological hallmark of Parkinson’s disease and dementia with Lewy bodies,…
  • 2025 International Congress

    Prevalence and Clinical Characteristics of iNPH-Related Imaging Findings (DESH) in Parkinson’s Disease

    T. Baba, T. Totsune, T. Nakamura, Y. Sugimura, H. Oizumi, H. Tanaka, T. Takahashi, M. Yoshioka, K. Nagamatsu, T. Hasegawa, A. Takeda (Sendai, Japan)

    Objective: To investigate the prevalence of idiopathic normal pressure hydrocephalus (iNPH)-related imaging findings (DESH) and their clinical characteristics in Parkinson’s disease (PD) patients. Background: PD…
  • 2025 International Congress

    MultiModal Transformer-Based Detection of Parkinson’s Disease in fMRI Extracted Time Series

    S. Patel, C. Antoniades, J. Fitzgerald, O. Bredemeyer (Oxford, United Kingdom)

    Objective: Develop and evaluate a multimodal, transformer-based pipeline for detecting Parkinson’s disease (PD) from resting-state fMRI time series, aiming to expose short-lived neural connectivity disruptions…
  • 2025 International Congress

    Brain hemodynamic responses to a motor control paradigm in younger and older adults, and people with Parkinson’s Disease: An fNIRS mediated feasibility study.

    M. Bjalme-Evans, K. Heffernan, D. Wani, S. Leung, J. Carter, A. Bowden, A. Raghunathan, L. Quinn (New York, USA)

    Objective: This study aims to investigate the use of fNIRS in measuring the hemodynamic response of the brain during motor control tasks of increasing complexity…
  • 2025 International Congress

    First in Class ASO Targeting A53T Allele: Preclinical Efficacy

    S. Smieszek, B. Przychodzen, C. Tyner, C. Polymeropoulos, G. Birznieks, M. Polymeropoulos (Washington, USA)

    Objective: Our objective was to develop an antisense oligonucleotide (ASO) allele-specific strategy to target the mutant A53T SNCA allele, reducing aberrant α-synuclein production, without downregulating…
  • 2025 International Congress

    Rapid Neurologic Decline after Subthalamic Nucleus Deep Brain Stimulation in Leucine-Rich Repeat Kinase 2 Parkinson’s disease (LRRK2-PD)

    T. Haddad, M. Rochman, TW. Liang (Phialdelphia, USA)

    Objective: To describe the clinical outcomes of two unrelated patients with LRRK2-PD who experienced rapid neurologic decline following subthalamic nucleus deep brain stimulation (STN-DBS). Background:…
  • « Previous Page
  • 1
  • …
  • 58
  • 59
  • 60
  • 61
  • 62
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley